Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (14)
2024
-
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Cancers, Vol. 16, Núm. 2
-
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity
European Journal of Heart Failure
2023
2020
-
Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next-generation sequencing gene panel
JIMD Reports, Vol. 51, Núm. 1, pp. 53-61
2019
-
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
Annals of Oncology, Vol. 30, Núm. 4, pp. 612-620
2018
-
Intestinal perforation secondary to intestinal diffuse large b-cell lymphoma in a patient with coeliac disease
Gastroenterologia y Hepatologia, Vol. 41, Núm. 8, pp. 503-504
2017
2014
-
Emergence and long-lasting persistence of linezolid-resistant enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid
Microbial Drug Resistance, Vol. 20, Núm. 1, pp. 17-21
-
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: Do we still need alkylators?
Blood, Vol. 124, Núm. 12, pp. 1887-1893
-
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Haematologica, Vol. 99, Núm. 10, pp. 1632-1637
2012
-
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
Blood, Vol. 120, Núm. 13, pp. 2581-2588
2011
-
Mortality risk factors in patients with zygomycosis: A retrospective and multicentre study of 25
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 4, pp. 263-268
2004
-
Chromosome 21 tandem repetition and AML1 (RUNX1) gene amplification
Cancer Genetics and Cytogenetics, Vol. 149, Núm. 1, pp. 11-16
1998
-
Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients diagnostic and clinical implications
Clinical and Experimental Immunology, Vol. 112, Núm. 3, pp. 410-418